Literature DB >> 26823729

Expression and functional role of miR-29b in renal cell carcinoma.

Yi Xu1, Jianyong Zhu1, Zhangming Lei1, Lijun Wan1, Xiuwen Zhu1, Feng Ye1, Yanyue Tong1.   

Abstract

OBJECTIVES: microRNAs (miRNAs) play essential roles in many tumors, including renal cell carcinoma (RCC). The aim of the present study was to investigate the expression and functional role of miR-29b in RCC and to identify its target genes.
METHODS: We determined the expression of miR-29b in clear cell RCC (ccRCC) tissues and RCC cell lines (786-O, A498, and SN12-PM6) using quantitative real-time PCR (qRT-PCR). The associations between miR-29b expression and clinical pathological parameters and prognosis were explored. Besides, the role of miR-29b in the SN12-PM6 cells proliferation, apoptosis, cycle, and invasion were investigated after transduction with lentivirus vectors. The kines in family member 1B (KIF1B), possible miR-29b target genes, were predicted using bioinformatics approaches, as well as the role in the pathogenesis of RCC.
RESULTS: Elevated expression of miR-29b was found in both tumor tissues and cell lines. High expression of miR-29b was significantly associated with tumor-node-metastasis (TNM) stage (P = 0.026) and the overall survival (P = 0.009) in the ccRCC. Inhibition of miR-29b expression could promote apoptosis, and inhibit proliferation and invasion ability in SN12-PM6 cells. Also, we confirmed that miR-29b could directly regulate the expression of KIF1B at the post transcriptional level.
CONCLUSION: These data suggest that miR-29b acts as an oncomiR, promoting proliferation and invasion ability through KIF1B suppression, and it might be a potential marker for prognosis of RCC.

Entities:  

Keywords:  Renal cell carcinoma; kinesin family member 1B; miR-29b

Mesh:

Substances:

Year:  2015        PMID: 26823729      PMCID: PMC4713515     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  36 in total

Review 1.  Small non-coding RNAs in animal development.

Authors:  Giovanni Stefani; Frank J Slack
Journal:  Nat Rev Mol Cell Biol       Date:  2008-03       Impact factor: 94.444

Review 2.  Oncogenes and cancer.

Authors:  Carlo M Croce
Journal:  N Engl J Med       Date:  2008-01-31       Impact factor: 91.245

3.  Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues.

Authors:  Zhengjun Yi; Yurong Fu; Shushu Zhao; Xuguang Zhang; Chuanxiang Ma
Journal:  J Cancer Res Clin Oncol       Date:  2009-11-17       Impact factor: 4.553

Review 4.  MicroRNAs--the micro steering wheel of tumour metastases.

Authors:  Milena S Nicoloso; Riccardo Spizzo; Masayoshi Shimizu; Simona Rossi; George A Calin
Journal:  Nat Rev Cancer       Date:  2009-03-05       Impact factor: 60.716

Review 5.  Renal cell carcinoma.

Authors:  Brian I Rini; Steven C Campbell; Bernard Escudier
Journal:  Lancet       Date:  2009-03-05       Impact factor: 79.321

6.  MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis.

Authors:  Todd Boren; Yin Xiong; Ardeshir Hakam; Robert Wenham; Sachin Apte; ZhengZheng Wei; Siddharth Kamath; Dung-Tsa Chen; Holly Dressman; Johnathan M Lancaster
Journal:  Gynecol Oncol       Date:  2008-05-21       Impact factor: 5.482

7.  KIF1Bbeta functions as a haploinsufficient tumor suppressor gene mapped to chromosome 1p36.2 by inducing apoptotic cell death.

Authors:  Arasambattu K Munirajan; Kiyohiro Ando; Akira Mukai; Masato Takahashi; Yusuke Suenaga; Miki Ohira; Tadayuki Koda; Toru Hirota; Toshinori Ozaki; Akira Nakagawara
Journal:  J Biol Chem       Date:  2008-07-09       Impact factor: 5.157

8.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

9.  NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma.

Authors:  Huating Wang; Ramiro Garzon; Hao Sun; Katherine J Ladner; Ravi Singh; Jason Dahlman; Alfred Cheng; Brett M Hall; Stephen J Qualman; Dawn S Chandler; Carlo M Croce; Denis C Guttridge
Journal:  Cancer Cell       Date:  2008-11-04       Impact factor: 31.743

10.  Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma.

Authors:  Yujuan Xiong; Jian-Hong Fang; Jing-Ping Yun; Jine Yang; Ying Zhang; Wei-Hua Jia; Shi-Mei Zhuang
Journal:  Hepatology       Date:  2010-03       Impact factor: 17.425

View more
  5 in total

1.  miR-514a-3p functions as a tumor suppressor in renal cell carcinoma.

Authors:  Lu Jin; Yifan Li; Zeng Zhang; Tao He; Jia Hu; Jiaju Liu; Mingwei Chen; Yaoting Gui; Shangqi Yang; Xiangming Mao; Yun Chen; Yongqing Lai
Journal:  Oncol Lett       Date:  2017-08-31       Impact factor: 2.967

2.  MiR-29b/TET1/ZEB2 signaling axis regulates metastatic properties and epithelial-mesenchymal transition in breast cancer cells.

Authors:  Hua Wang; Xinglan An; Hao Yu; Sheng Zhang; Bo Tang; Xueming Zhang; Ziyi Li
Journal:  Oncotarget       Date:  2017-10-31

Review 3.  MicroRNA Signature in Renal Cell Carcinoma.

Authors:  Soudeh Ghafouri-Fard; Zeinab Shirvani-Farsani; Wojciech Branicki; Mohammad Taheri
Journal:  Front Oncol       Date:  2020-11-30       Impact factor: 6.244

Review 4.  miRNAs in Prediction of Prognosis in Clear Cell Renal Cell Carcinoma.

Authors:  LongJiao Ran; Jian Liang; Xin Deng; JinYu Wu
Journal:  Biomed Res Int       Date:  2017-12-17       Impact factor: 3.411

5.  Plasma exosomal miRNAs-based prognosis in metastatic kidney cancer.

Authors:  Meijun Du; Karthik V Giridhar; Yijun Tian; Michael R Tschannen; Jing Zhu; Chiang-Ching Huang; Deepak Kilari; Manish Kohli; Liang Wang
Journal:  Oncotarget       Date:  2017-07-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.